FT: Weight-loss drugs reduce risk of Alzheimer’s, large study shows

Key topics

• GLP-1 drugs like Ozempic reduce Alzheimer's risk by 12%, study finds.
• Weight-loss treatments show benefits for 42 conditions, including cognitive health.
• Risks include higher rates of arthritis, kidney, and pancreatic disorders.

Sign up for your early morning brew of the BizNews Insider to keep you up to speed with the content that matters. The newsletter will land in your inbox at 5:30am weekdays. Register here.

The seventh BizNews Conference, BNC#7, is to be held in Hermanus from March 11 to 13, 2025. The 2025 BizNews Conference is designed to provide an excellent opportunity for members of the BizNews community to interact directly with the keynote speakers, old (and new) friends from previous BNC events – and to interact with members of the BizNews team. Register for BNC#7 here.

If you prefer WhatsApp for updates, sign up to the BizNews channel here.

By Clive Cookson and Michael Peel in London

Analysis of drugs such as Ozempic finds a lower health risk for 42 conditions but a higher rate of disorders such as arthritis

___STEADY_PAYWALL___